论文部分内容阅读
目的探讨小儿肺炎采用舒普深与头孢哌酮治疗的临床疗效和应用价值。方法 66例小儿肺炎患儿,随机分为对照组和观察组,各33例。对照组给予头孢哌酮治疗,观察组给予舒普深治疗,对比两种治疗方法的应用效果。结果观察组患儿治疗总有效率为97.0%,对照组为78.8%,两组比较,差异具有统计学意义(P<0.05)。观察组患儿咳嗽、发热、喘息和肺部啰音等各项临床症状和体征消失时间显著短于对照组(P<0.05)。治疗后,两组患儿不良反应发生率比较差异无统计学意义(P>0.05)。结论采用舒普深治疗小儿肺炎,可有效缓解患儿咳嗽、发热、喘息和肺部啰音等各项临床症状和体征,缩短其临床症状和体征消失时间,且用药后患儿不良反应较少,治疗效果良好,具有临床推广价值。
Objective To investigate the clinical efficacy and clinical value of Shu Pu Shen and cefoperazone in children with pneumonia. Methods 66 cases of children with pneumonia were randomly divided into control group and observation group, 33 cases in each. The control group was given cefoperazone treatment, the observation group was treated with Shu Pu Shen, compared with the application of the two treatment methods. Results The total effective rate of treatment group was 97.0% in the observation group and 78.8% in the control group, the difference was statistically significant (P <0.05). The clinical symptoms and signs of cough, fever, wheezing and pulmonary rales in observation group were significantly shorter than those in control group (P <0.05). After treatment, the incidence of adverse reactions in both groups was no significant difference (P> 0.05). Conclusions Shuxunshen treatment of children with pneumonia can effectively relieve the clinical symptoms and signs of cough, fever, wheezing and pulmonary rales in children, shorten the clinical symptoms and signs of disappearance of time, and children with adverse reactions less , The treatment effect is good, with clinical promotion value.